944 resultados para 67-498


Relevância:

20.00% 20.00%

Publicador:

Resumo:

Endothelial cell association with vascular basement membranes is complex and plays a critical role in regulation of cell adhesion and proliferation. The interaction between the membrane-associated 67-kd receptor (67LR) and the basement membrane protein laminin has been studied in several cell systems where it was shown to be crucial for adhesion and attachment during angiogenesis. As angiogenesis in the pathological setting of proliferative retinopathy is a major cause of blindness in the Western world we examined the expression of 67LR in a murine model of hyperoxia-induced retinopathy that exhibits retinal neovascularization. Mice exposed to hyperoxia for 5 days starting at postnatal day 7 (P7) and returned to room air (at P12) showed closure of the central retinal vasculature. In response to the ensuing retinal ischemia, there was consistent preretinal neovascularization starting around P17, which persisted until P21, after which the new vessels regressed. Immunohistochemistry was performed on these retinas using an antibody specific for 67LR. At P12, immunoreactivity for 67LR was absent in the retina, but by P17 it was observed in preretinal proliferating vessels and also within the adjacent intraretinal vasculature. Intraretinal 67LR immunoreactivity diminished beyond P17 until by P21 immunoreactivity was almost completely absent, although it persisted in the preretinal vasculature. Control P17 mice (not exposed to hyperoxia) failed to demonstrate any 67LR immunoreactivity in their retinas. Parallel in situ hybridization studies demonstrated 67LR gene expression in the retinal ganglion cells of control and hyperoxia-exposed mice. In addition, the neovascular intra- and preretinal vessels of hyperoxia-treated P17 and P21 mice labeled strongly for 67LR mRNA. This study has characterized 67LR immunolocalization and gene expression in a murine model of ischemic retinopathy. Results suggest that, although the 67LR gene is expressed at high levels in the retinal ganglion cells, the mature receptor protein is preferentially localized to the proliferating retinal vasculature and is almost completely absent from quiescent vessels. The differential expression of 67LR between proliferating and quiescent retinal vessels suggests that this laminin receptor is an important and novel target for future chemotherapeutic intervention during proliferative vasculopathies.

Relevância:

20.00% 20.00%

Publicador:

Resumo:

The 67LR (67 kDa laminin receptor) enables cells to interact with components of the extracellular matrix The molecule is derived from the 37LRP (37 kDa laminin receptor precursor); however, the precise molecular mechanism of this conversion is unknown. Recombinant 37LRP expressed in and purified from Escherichia colt, bound to human laminin in a SPR (surface plasmon resonance) experiment. 67LR isolated from human breast-cancer-derived cells in culture was also shown to bind to laminin by SPR. However, the kinetics of association are qualitatively different. 37LRP but not 67LR, binds to heparan sulfate. The binding of 37LRP to heparan sulfate did not affect the interaction of 37LRP with laminin In contrast, heparan sulfate reduces the extent of binding of laminin to 67LR. Taken together, these results show that 37LRP has some of the biological activities of 67LR, even prior to the conversion event. However, the conversion affects the sites of interaction with both laminin and heparan sulfate.

Relevância:

20.00% 20.00%

Publicador:

Resumo:

BACKGROUND: Worldwide data for cancer survival are scarce. We aimed to initiate worldwide surveillance of cancer survival by central analysis of population-based registry data, as a metric of the effectiveness of health systems, and to inform global policy on cancer control.

METHODS: Individual tumour records were submitted by 279 population-based cancer registries in 67 countries for 25·7 million adults (age 15-99 years) and 75,000 children (age 0-14 years) diagnosed with cancer during 1995-2009 and followed up to Dec 31, 2009, or later. We looked at cancers of the stomach, colon, rectum, liver, lung, breast (women), cervix, ovary, and prostate in adults, and adult and childhood leukaemia. Standardised quality control procedures were applied; errors were corrected by the registry concerned. We estimated 5-year net survival, adjusted for background mortality in every country or region by age (single year), sex, and calendar year, and by race or ethnic origin in some countries. Estimates were age-standardised with the International Cancer Survival Standard weights.

FINDINGS: 5-year survival from colon, rectal, and breast cancers has increased steadily in most developed countries. For patients diagnosed during 2005-09, survival for colon and rectal cancer reached 60% or more in 22 countries around the world; for breast cancer, 5-year survival rose to 85% or higher in 17 countries worldwide. Liver and lung cancer remain lethal in all nations: for both cancers, 5-year survival is below 20% everywhere in Europe, in the range 15-19% in North America, and as low as 7-9% in Mongolia and Thailand. Striking rises in 5-year survival from prostate cancer have occurred in many countries: survival rose by 10-20% between 1995-99 and 2005-09 in 22 countries in South America, Asia, and Europe, but survival still varies widely around the world, from less than 60% in Bulgaria and Thailand to 95% or more in Brazil, Puerto Rico, and the USA. For cervical cancer, national estimates of 5-year survival range from less than 50% to more than 70%; regional variations are much wider, and improvements between 1995-99 and 2005-09 have generally been slight. For women diagnosed with ovarian cancer in 2005-09, 5-year survival was 40% or higher only in Ecuador, the USA, and 17 countries in Asia and Europe. 5-year survival for stomach cancer in 2005-09 was high (54-58%) in Japan and South Korea, compared with less than 40% in other countries. By contrast, 5-year survival from adult leukaemia in Japan and South Korea (18-23%) is lower than in most other countries. 5-year survival from childhood acute lymphoblastic leukaemia is less than 60% in several countries, but as high as 90% in Canada and four European countries, which suggests major deficiencies in the management of a largely curable disease.

INTERPRETATION: International comparison of survival trends reveals very wide differences that are likely to be attributable to differences in access to early diagnosis and optimum treatment. Continuous worldwide surveillance of cancer survival should become an indispensable source of information for cancer patients and researchers and a stimulus for politicians to improve health policy and health-care systems.


Relevância:

20.00% 20.00%

Publicador:

Resumo:

Revista elaborada pela Assessoria de Comunicação e Imprensa da Reitoria da UNESP

Relevância:

20.00% 20.00%

Publicador:

Resumo:

BACKGROUND: Worldwide data for cancer survival are scarce. We aimed to initiate worldwide surveillance of cancer survival by central analysis of population-based registry data, as a metric of the effectiveness of health systems, and to inform global policy on cancer control. METHODS: Individual tumour records were submitted by 279 population-based cancer registries in 67 countries for 25·7 million adults (age 15-99 years) and 75 000 children (age 0-14 years) diagnosed with cancer during 1995-2009 and followed up to Dec 31, 2009, or later. We looked at cancers of the stomach, colon, rectum, liver, lung, breast (women), cervix, ovary, and prostate in adults, and adult and childhood leukaemia. Standardised quality control procedures were applied; errors were corrected by the registry concerned. We estimated 5-year net survival, adjusted for background mortality in every country or region by age (single year), sex, and calendar year, and by race or ethnic origin in some countries. Estimates were age-standardised with the International Cancer Survival Standard weights. FINDINGS: 5-year survival from colon, rectal, and breast cancers has increased steadily in most developed countries. For patients diagnosed during 2005-09, survival for colon and rectal cancer reached 60% or more in 22 countries around the world; for breast cancer, 5-year survival rose to 85% or higher in 17 countries worldwide. Liver and lung cancer remain lethal in all nations: for both cancers, 5-year survival is below 20% everywhere in Europe, in the range 15-19% in North America, and as low as 7-9% in Mongolia and Thailand. Striking rises in 5-year survival from prostate cancer have occurred in many countries: survival rose by 10-20% between 1995-99 and 2005-09 in 22 countries in South America, Asia, and Europe, but survival still varies widely around the world, from less than 60% in Bulgaria and Thailand to 95% or more in Brazil, Puerto Rico, and the USA. For cervical cancer, national estimates of 5-year survival range from less than 50% to more than 70%; regional variations are much wider, and improvements between 1995-99 and 2005-09 have generally been slight. For women diagnosed with ovarian cancer in 2005-09, 5-year survival was 40% or higher only in Ecuador, the USA, and 17 countries in Asia and Europe. 5-year survival for stomach cancer in 2005-09 was high (54-58%) in Japan and South Korea, compared with less than 40% in other countries. By contrast, 5-year survival from adult leukaemia in Japan and South Korea (18-23%) is lower than in most other countries. 5-year survival from childhood acute lymphoblastic leukaemia is less than 60% in several countries, but as high as 90% in Canada and four European countries, which suggests major deficiencies in the management of a largely curable disease. INTERPRETATION: International comparison of survival trends reveals very wide differences that are likely to be attributable to differences in access to early diagnosis and optimum treatment. Continuous worldwide surveillance of cancer survival should become an indispensable source of information for cancer patients and researchers and a stimulus for politicians to improve health policy and health-care systems. FUNDING: Canadian Partnership Against Cancer (Toronto, Canada), Cancer Focus Northern Ireland (Belfast, UK), Cancer Institute New South Wales (Sydney, Australia), Cancer Research UK (London, UK), Centers for Disease Control and Prevention (Atlanta, GA, USA), Swiss Re (London, UK), Swiss Cancer Research foundation (Bern, Switzerland), Swiss Cancer League (Bern, Switzerland), and University of Kentucky (Lexington, KY, USA).

Relevância:

20.00% 20.00%

Publicador:

Resumo:

Contient : « Ci commence le Chastoiement que li peres ensaigne à son filz. » Barbazan et Méon, Fabliaux et contes, II, 40 ; Fables de MARIE DE FRANCE. « Ci commence de Ysopes. Cil qui sevent de l'estreure... » ; «... Que ge li puisse l'ame rendre. Explicit de Ysopes » ; « Ci commence des XV signes. Se ne vos quidasse annuier... » ; «... Explicit des XV signes. » Cf. Romania, VI, 23 ; « Ci commence de seinte Leocade, qui fu dame de Tolete, et du saint arcevesque », par GAUTIER DE COINCY. Barbazan et Méon, I, 270, et Poquet, Les Miracles de la sainte Vierge, col. 77 ; « De quoi viennent li traitor et li mauvés. Or escoutez, et cler et lai... » Cf. Paulin Paris, Hist. littér. de la France, XXIII, 285 ; « Du cors et de l'ame. Cors en toi n'a point de savoir... » ; « D'un preudome qui rescolt son compere de noier. » Montaiglon, Recueil général et complet des fabliaux, I, 301 ; « Du segretain moine. » Montaiglon et Raynaud, Recueil... des fabliaux, V, 215 ; « Des eles de cortoisie», par RAOUL DE HOUDAN . Cf. Romania, IX, 150 ; « Ci commance de Florance et Blancheflor. » Barbazan et Méon, IV, 358 ; « D'un mercier. » G.-A. Crapelet, Proverbes et dictons populaires aux XIIIe et XIVe siècles (1831), p. 149 ; cf. Hist. littér. de la France, XXIII, 184 ; « Ci commence de la dame escolliée. » Montaiglon et Raynaud, Recueil... des fabliaux, VI, 95 ; « D'un jugleor qui ala en enfer et perdi les ames as dez. » Ibid., V, 65 ; Du vilain qui conquist paradis par plait. » Ibid., III, 209 ; « De II Angloys et de l'agnel. » Ibid., II, 178 ; « Du foteor. » Ibid., I, 304 ; « Du prestre et d'Alison », par GUILLAUME LE NORMAND. Ibid., II, 8 ; « Del convoiteus et de l'envieus », titre erroné pour « Estula ». Ibid., IV, 87 ; « Du convoitox », par JEAN DE BOVES. Ibid., V, 211 ; « De Haimet et de Barat, etc. » Ibid., IV, 93 ; « De Bérangier au lonc cul », par GUERIN. Ibid., III, 253 ; « De la pucele qui abevra le polain. » Ibid., IV, 199 ; « Du vilain asnier. » Ibid., V, 40 ; « Du provoire qui menga les meures. » Ibid., IV, 53 ; « De la damoiselle à la grue », par GARIN, Ibid., V, 151 ; « Du prestre qui ot mere malgré sien. » Ibid., V, 143 ; « Du chevalier qui fist les c... parler », par GUERIN. Ibid., VI, 68 ; « De Guillaume au faucon. » Ibid., II, 92 ; « De la male honte », par GUILLAUME LE NORMAND. Ibid., IV, 41 ; « Du c... Guautiers li leus dit a devise... » ; « ... Mais que ce fust li rois de France. Explicit du c... » ; « Du prestre qui dist la Passion. » Ibid., V, 80 ; « Du prestre et de la dame. » Ibid, II, 235 ; « De Audigier. » Barbazan et Méon, Fabliaux et contes, IV, 217 ; « De II bordeors ribauz. » Montaiglon, Recueil général... des fabliaux. I, 1 ; « La response de l'un des II ribauz. » Ibid, I, 7 ; « Du chevalier tort. » Barbazan et Méon, III, 444 ; « De l'apostoile. » G.-A. Crapelet, Proverbes et dictons populaires..., pp. 1-123 ; « D'Alixandre et d'Aristote. » Lai d'Aristote, par HENRI D'ANDELI. Montaiglon et Raynaud, Recueil, etc., V, 243 ; manuscrit C de l'édition des OEuvres d'Henri d'Andeli, par A. Héron, 1880, p. 1 ; « Des proverbes et du vilain. Qui vult oïr bons dis, Bons proverbes, bons ris... » Le texte est en grande partie différent de celui qu'a publié Le Roux de Lincy, Le Livre des Proverbes français, t. II (1859), pp. 459-470 ; « De Constant Du Hamel. » Montaiglon et Raynaud, Recueil, etc., IV, 166 ; « D'Auberée la vielle maquerel[le]. » Ibid., V, 1 ; « Ci comence le cortois d'Artois. » Barbazan et Méon, Fabliaux et contes, I, 356 ; « Ci comence de l'onbre et de l'anel. » Cf. Legrand d'Aussi, Fabliaux (1829), I, 256 ; « Ci comence l'erberie. » Rutebeuf, édit. Ach. Jubinal, 1839, t. I, Notes et éclaircissements, pp. 468-475, et 1875, t. III, Notes et éclaircissements, pp. 182-192 ; « Ci comence la bataille de quaresme et de charnage. » Barbazan et Méon, Fabliaux et contes, IV, 80 ; « Ci comence de Ovide, de Arte. Entendez tuit, grant et petit, Ce que maistre ÉLIE nos dit... » ; «... Que de cest mal, par s. Johan, N'aurez vos jà fors que l'ahan. » Cf. Gaston Paris, Hist. littér. de la France, XXIX, 458-461 ; « Ci commence de Piramo et de Tisbe. » Barbazan et Méon, Fabliaux et contes, IV, 326 ; cf. Gaston Paris, Hist. littér. de la France, XXIX, 498 ; « Ci commence Doctrinal de latin en roumans » [Doctrinal sauvage]. Cf. P. Meyer, Romania, VI, 20-22, et Notices et extraits des manuscrits, t. XXXIII, 1re partie, pp. 45-46 ; « Ci commence de la chante-pleure. » Cf. P. Meyer, Romania, VI, 26, et IX, 510 ; « Ci commence chastie-musart. » Cf. P. Meyer, Romania, XV, 604 et suiv ; « Ci commence la desputoison du juyf et du chrestien. Omnis credencium letetur populus... » ; «... Puis que j'ay I juyf à creance amené. Explicit. » Cf. Hist. littér. de la France, XXIII, 217 ; « Ci coumence d'amors et de jalousie. Comencer vueil I poi d'afaire, Que plus ne s'en puet mon cuer taire... » ; «... Ou jamais nul n'i faudrai. Explicit » ; « La bataille des VII arz », par HENRI D'ANDELI. A. Héron, OEuvres d'Henri d'Andeli, p. 43 ; « Ci commencent les proverbes au conte de Bretaigne. » G.-A. Crapelet, Proverbes et dictons populaires, p. 169 ; cf. Hist. littéraire de la France, XXIII, 686-688 ; « Ci coumence de Marcoul et de Salemon, que li cuens de Bretagne fist. » G.-A. Crapelet, Ibid., p. 189 ; cf. Hist. littér. de la France, XXIII, 688-689 ; « Ci coumence de Narciso le roumanz. » Barbazan et Méon, Fabliaux et contes, IV, 143 ; cf. Gaston Paris, Hist. littér. de la France, XXIX, 498-499 ; « C'est li romanz des braies » [les braies du Cordelier]. Montaiglon et Raynaud, Recueil général... des fabliaux, III, 275 ; « Commence des tresces. » Ibid., IV, 67 ; Partonopex de Blois. Ms. utilisé dans l'édition G.-A. Crapelet, 1834 ; « C'est le romanz de Blanchandin et de Orgueillose d'amors. » Cf. l'édition Michelant, 1867, et Romania, XVIII, 290 ; « Ci commence le romanz de Floire et de Blanche-Flor. » Seconde version d' Édélestand Du Méril ; édition Éd. Du Méril (1856), pp. CCVII-CCVIII et 125-227

Relevância:

20.00% 20.00%

Publicador:

Resumo:

Contient : 1° « Sciendum des notaires et secretaires du roy » ; 2° Règlement pour la tenue du conseil d'Etat, fait par le roi Charles IX. Paris 23 octobre 1563 ; 3° « Règlement faict par le roy [Charles IX] pour la court de parlement et envoyé en icelle par mons. le mareschal de Montmorency ». Paris, 13 octobre 1563 ; Lettre d'envoi du susd. règlement. Paris, 13 octobre 1563 ; 4° « S'ensuivent les noms de messieurs les maistres des requêtes en l'année MVe LXIII » ; 5° « Quartiers de messieurs les maistres des requestes ordinaires de l'hostel du roy » ; « Service de chancellerie, court de parlement, et requestes de l'hostel... Les presens quartiers ont esté faictz... le XVIe jour de mars 1561 »

Relevância:

20.00% 20.00%

Publicador:

Resumo:

Contient : 1° L'Histoire universelle [de GUILLAUME, de Nangis] ; 2° Histoire de la guerre sainte [de GUILLAUME, de Tyr], avec continuation